U
GrantUnlock
Science & Technology

A Multivalent mRNA Vaccine to Prevent Transmission of Tick-bornePathogens

Department of Health and Human Services — National Institutes of Health

Opportunity #: 1R41AI179587-01A1

Award Ceiling
$598K
Award Floor
$598K
Close Date
Apr 30, 2026
46 days left
Total Funding
$598K
Expected Awards
1
Posted Date
May 1, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1R41AI179587-01A1

Description

STTR Phase Phase I award: "A Multivalent mRNA Vaccine to Prevent Transmission of Tick-bornePathogens" awarded to L2 DIAGNOSTICS LLC in NEW HAVEN, Connecticut. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $597,612. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov
Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.